展會預(yù)告 | 博騰股份積極參與歐洲CPhI，精彩演講即將揭幕！

一口蝴蝶酥

　　全球**業(yè)的盛會——世界制藥原料展(CPhI)即將于今年10月在美麗的意大利米蘭拉開帷幕。這一盛會已經(jīng)成為全球**界開展商貿(mào)交流和信息共享的重要平臺。預(yù)計將吸引來自超過166個國家和地區(qū)的6.2萬名參與者，展商數(shù)量超過2400家，勢必再次掀起**行業(yè)的熱潮。
　　為了更好地與行業(yè)同仁互動，博騰股份特別在第二天(10月9日)安排了兩場在展位5C17的專業(yè)演講活動。我們的兩位技術(shù)專家將為您帶來前沿的技術(shù)分享和行業(yè)洞見，其詳細(xì)日程如下：

　　分享主題
　　?主題一：
　　博騰斯洛文尼亞：推動CDMO行業(yè)創(chuàng)新，夯實全球化布局
　　?主題二：
　　制粒工程在原料藥和制劑研發(fā)中的應(yīng)用
　　此次分享活動將為您全面展示博騰股份在全球化步伐、技術(shù)研發(fā)和創(chuàng)新方面的最新成果，為您提供新視角和新思路，助力您在激烈的市場競爭中贏得先機。
　　期待與您相聚米蘭，共同見證**產(chǎn)業(yè)的美好未來!

　　Presenter Profile

　　SVP, Head of Global Chemical Engineering and Technology Center, Porton Pharma Solutions
　　31-year experience in Pharma industry
　　Joined Porton JSTAR in 2014. previously served as the Head of Center for Pharma Crystallization, Dr. Jian Wanghas over 30 years of process R&D experience specialized in API crystallization, reaction engineering, and PAT applications. Jian earned her Ph.D. in Chemical Engineering in 1994 from University of Pittsburgh, supervised by Prof. Donna Blackmond and Prof. Irving Winder. She has authored over 20 peer-reviewed articles and holds 6 patents, 5 on API crystallization.
　　From 1994 to 2005. Jian worked at Merck, addressing bottleneck process R&D issues via reaction engineering, API crystallization, and PAT application, as well as pilot plant process execution. She consulted at Mettler Toledo AutoChem from 2005-2010 and served as VP of Crystallization Development at Crystal Pharmatech from 2011-2013. Since 2014. she established a state-of-the-art crystallization center at J-STAR Research, working on API isolation challenges across developmental stages and integrating drug formulation services with API crystallization R&D.
　　Listening to clients’ needs, building up the team’s technical capabilities, and providing the right technical solutions have been Jian’s focus for decades. Her dedication and contributions to pharma process R&D have served broad needs of diverse global clients with technical rigor, synergy and efficiency.
　　博騰股份為全球藥企、生物科技公司、科研機構(gòu)等提供從臨床前研究到藥品上市全生命周期所需的小分子藥物、多肽與寡核苷酸藥物、蛋白與偶聯(lián)藥物以及細(xì)胞與基因治療藥物等一站式服務(wù)解決方案，研發(fā)、生產(chǎn)、運營場地覆蓋中國(重慶、上海、四川、江蘇、江西、湖北)、美國、斯洛文尼亞、比利時、瑞士和丹麥等地。我們致力于以客戶為中心，為客戶提供卓越的全球化、端到端CDMO服務(wù)，讓好藥更早惠及大眾。